VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation
ONWARD receives new FDA Breakthrough Device Designations for bladder control, alleviation of spasticity, and blood pressure regulation after spinal cord injury